0,957  0,002  Spasmolytic
0,853  0,001  Antiparkinsonian, tremor relieving
0,811  0,003  Anesthetic
0,808  0,005  Respiratory analeptic
0,785  0,003  Cholinergic antagonist
0,766  0,003  Acetylcholine antagonist
0,739  0,006  Analeptic
0,724  0,013  Embryotoxic
0,718  0,015  Teratogen
0,659  0,003  Acetylcholine muscarinic antagonist
0,655  0,003  Acetylcholine M1 receptor antagonist
0,650  0,019  Analgesic
0,627  0,004  Sulfotransferase substrate
0,619  0,003  Acetylcholine nicotinic antagonist
0,620  0,007  Ulceration
0,631  0,018  CYP2C9 substrate
0,584  0,005  Irritable Bowel syndrome treatment
0,586  0,009  Cardiodepressant
0,582  0,010  Eye irritation, high
0,579  0,031  CYP3A4 substrate
0,536  0,010  Dependence treatment
0,523  0,009  Psychostimulant
0,520  0,007  Antiulcerative
0,529  0,020  Sensitization
0,506  0,015  Cardiotonic
0,499  0,008  Anesthetic general
0,502  0,020  NOS3 expression inhibitor
0,512  0,035  Antiparkinsonian
0,485  0,009  Antiarrhythmic
0,484  0,009  P-glycoprotein inhibitor
0,476  0,008  Diabetic retinopathy treatment
0,466  0,004  Antiemetic
0,474  0,012  Sedative
0,463  0,018  Chronic obstructive pulmonary disease treatment
0,478  0,052  TNF expression inhibitor
0,418  0,005  Acute respiratory distress syndrome (ARDS) treatment
0,412  0,003  Dopamine transporter inhibitor
0,413  0,005  Bronchodilator
0,420  0,012  Sodium/bile acid cotransporter inhibitor
0,458  0,051  Transcription factor NF kappa B inhibitor
0,414  0,008  Alpha-N-acetylglucosaminidase inhibitor
0,447  0,045  Antiasthmatic
0,444  0,051  Antipruritic, allergic
0,486  0,093  Antiinflammatory
0,389  0,003  Acetylcholine M3 receptor antagonist
0,391  0,010  Pneumotoxic
0,386  0,006  Cocaine dependence treatment
0,382  0,003  Antihypermotility
0,406  0,034  CYP2D6 inhibitor
0,368  0,004  Acetylcholine M2 receptor antagonist
0,416  0,054  Toll-Like receptor agonist
0,415  0,054  Toll-Like receptor 7 agonist
0,365  0,008  Anesthetic local
0,384  0,034  Carcinogenic
0,359  0,009  Antidiarrheal
0,386  0,040  CTGF expression inhibitor
0,364  0,022  Abortion inducer
0,362  0,022  5 Hydroxytryptamine uptake stimulant
0,339  0,011  Antidote
0,361  0,040  UGT2B4 substrate
0,353  0,035  Antidiabetic symptomatic
0,365  0,059  Cholesterol antagonist
0,295  0,004  Acetylcholine M4 receptor antagonist
0,305  0,018  Lipid peroxidase inhibitor
0,287  0,001  Antidote, organophosphates
0,344  0,062  Antifungal
0,382  0,101  Cyclophilin D inhibitor
0,382  0,101  Antidiabetic
0,290  0,009  Expectorant
0,289  0,012  UGT2B9 substrate
0,264  0,004  Acetylcholine muscarinic agonist
0,262  0,004  Antiemphysemic
0,277  0,025  Skin irritative effect
0,284  0,033  UGT1A4 substrate
0,256  0,007  Movement disorders treatment
0,318  0,072  CYP2D6 substrate
0,336  0,094  Immunosuppressant
0,297  0,054  Tumour necrosis factor alpha release inhibitor
0,244  0,005  Chronic obstructive bronchitis treatment
0,292  0,052  Angiogenesis stimulant
0,296  0,057  Radiosensitizer
0,245  0,008  5 Hydroxytryptamine uptake inhibitor
0,250  0,015  Antitussive
0,269  0,035  UGT2B7 substrate
0,310  0,082  Antithrombotic
0,320  0,094  Cognition disorders treatment
0,296  0,077  Interleukin 2 agonist
0,225  0,007  Neuronal nicotinic receptor antagonist
0,322  0,109  CYP2C19 inhibitor
0,278  0,066  Chemoprotective
0,270  0,059  Hypolipemic
0,221  0,013  Cyclooxygenase 3 inhibitor
0,213  0,006  Dopamine uptake inhibitor
0,257  0,052  Mutagenic
0,233  0,027  Allergic rhinitis treatment
0,214  0,011  Mucolytic
0,272  0,069  Antihypercholesterolemic
0,238  0,038  Lipocortins synthesis antagonist
0,289  0,094  FMO1 substrate
0,206  0,013  Acetylcholine agonist
0,271  0,080  Antihypoxic
0,269  0,080  Lipoprotein disorders treatment
0,295  0,113  GST A substrate
0,255  0,074  Antipyretic
0,226  0,045  Antipruritic, non-allergic
0,271  0,091  Antiischemic
0,181  0,005  Dopamine D5 antagonist
0,192  0,016  Antineoplastic alkaloid
0,236  0,062  Peptidyltransferase inhibitor
0,178  0,008  Ca2+-transporting ATPase inhibitor
0,187  0,017  Antineoplastic, alkylator
0,203  0,035  Antirickettsial
0,206  0,045  Cytidine deaminase inhibitor
0,237  0,076  DNA synthesis inhibitor
0,199  0,038  UGT2B10 substrate
0,164  0,004  Acetylcholine M5 receptor agonist
0,206  0,048  VEGF expression inhibitor
0,206  0,048  UGT1A3 substrate
0,250  0,093  Radioprotector
0,160  0,007  Acetylcholine M5 receptor antagonist
0,323  0,170  Caspase 9 stimulant
0,215  0,063  UDP-glucuronosyltransferase substrate
0,187  0,037  Antinephritic
0,161  0,013  Analgesic, opioid
0,156  0,009  Adrenaline uptake inhibitor
0,149  0,007  Glycine receptor agonist
0,232  0,090  Proliferative diseases treatment
0,214  0,076  Antiparkinsonian, rigidity relieving
0,204  0,068  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,183  0,054  ATPase inhibitor
0,201  0,071  UGT1A1 substrate
0,180  0,053  Arachidonic acid antagonist
0,231  0,104  Immunostimulant
0,225  0,101  UGT1A9 substrate
0,144  0,025  Toll-Like receptor 4 antagonist
0,245  0,128  ICAM1 expression inhibitor
0,205  0,089  UGT1A6 substrate
0,182  0,067  Muscle relaxant
0,178  0,064  Toxic, respiratory center
0,169  0,056  Protein kinase stimulant
0,191  0,078  Non-steroidal antiinflammatory agent
0,172  0,060  Uterine stimulant
0,142  0,033  UGT2B1 substrate
0,165  0,058  Aldose reductase substrate
0,172  0,068  Aldehyde oxidase substrate
0,121  0,019  ATPase (Vacuolar H+) inhibitor
0,119  0,018  Nicotinic alpha4beta2 receptor antagonist
0,139  0,039  Constipation treatment
0,147  0,047  Adenylate cyclase inhibitor
0,181  0,083  Antimigraine
0,156  0,060  Skeletal muscle relaxant
0,129  0,035  Acetylcholine release stimulant
0,110  0,018  Narcotic antagonist
0,210  0,118  Tyrosine 3 hydroxylase inhibitor
0,141  0,049  Cholesterol synthesis inhibitor
0,168  0,076  Phospholipase C inhibitor
0,106  0,015  Anticholelithogenic
0,117  0,028  Antibiotic
0,152  0,064  Cell wall synthesis inhibitor
0,106  0,019  Estrogen-related receptor beta agonist
0,094  0,007  Alpha-mannosidase inhibitor
0,098  0,013  Antiviral (Parainfluenza)
0,220  0,135  FMO3 substrate
0,159  0,077  Antihelmintic (Nematodes)
0,091  0,009  Andropause treatment
0,128  0,047  Choleretic
0,103  0,024  Antiviral (Dengue virus)
0,149  0,070  UGT2B15 substrate
0,187  0,111  Platelet antagonist
0,129  0,052  Alcohol dehydrogenase substrate
0,161  0,086  Nitric oxide antagonist
0,132  0,057  Growth stimulant
0,193  0,119  Antioxidant
0,078  0,009  Mannosidase inhibitor
0,214  0,147  AR expression inhibitor
0,108  0,041  Triose-phosphate isomerase inhibitor
0,199  0,134  CYP2C19 substrate
0,210  0,147  Mood disorders treatment
0,109  0,046  UGT2B11 substrate
0,083  0,023  Androgen agonist
0,158  0,100  Cytotoxic
0,087  0,031  Prokinetic
0,101  0,046  Antineoplastic antibiotic
0,194  0,139  Flavin-containing monooxygenase substrate
0,145  0,091  Carcinogenic, group 1
0,214  0,160  Vasodilator, peripheral
0,111  0,057  Antiviral (Poxvirus)
0,078  0,024  Antimycoplasmal
0,057  0,003  Vesicular acetylcholine transporter inhibitor
0,117  0,064  Microtubule formation inhibitor
0,107  0,054  UDP-glucose 4-epimerase inhibitor
0,141  0,091  Interferon gamma antagonist
0,119  0,069  Antiviral (Influenza B)
0,226  0,177  Calcium channel activator
0,137  0,088  Cholinergic
0,214  0,165  GST M1-1 substrate
0,203  0,154  Nootropic
0,066  0,018  Nicotinic receptor alpha4 subunit antagonist
0,066  0,018  Glucose-6-phosphate translocase inhibitor
0,123  0,075  Antihyperlipoproteinemic
0,183  0,136  Interleukin agonist
0,215  0,168  Vasodilator, coronary
0,101  0,054  Prolactin inhibitor
0,236  0,190  Antibacterial
0,094  0,049  Acetylcholine M3 receptor agonist
0,103  0,059  Anabolic
0,253  0,211  Apoptosis agonist
0,196  0,155  Gastrin inhibitor
0,133  0,092  Antifungal (Cryptococcus)
0,100  0,059  Sphingomyelinase inhibitor
0,148  0,108  Platelet adhesion inhibitor
0,060  0,022  Acetylcholine M1 receptor agonist
0,051  0,012  Vesicle monoamine transporter inhibitor
0,105  0,067  Rhinitis treatment
0,065  0,028  Peristaltic stimulant
0,112  0,076  Alkylator
0,039  0,004  1,3-Beta-glucan synthase inhibitor
0,077  0,043  Phosphofructokinase-1 inhibitor
0,134  0,102  Growth hormone agonist
0,154  0,123  Antihypertriglyceridemic
0,145  0,115  Antihelmintic
0,223  0,194  Atherosclerosis treatment
0,160  0,130  Aldehyde oxidase inhibitor
0,058  0,029  Nicotinic alpha3beta2 receptor antagonist
0,128  0,100  Antiviral (Herpes)
0,045  0,017  Cholesterol absorption inhibitor
0,052  0,026  Glucose-6-phosphate isomerase inhibitor
0,125  0,099  SULT1A3 substrate
0,094  0,069  Tourette's syndrome treatment
0,083  0,058  Antispirochetal
0,060  0,036  Lipocortins synthesis agonist
0,081  0,057  Opioid kappa receptor antagonist
0,081  0,057  Histamine H1 receptor antagonist
0,063  0,040  Carbamoyl phosphate synthetase inhibitor
0,077  0,054  Na+ K+ transporting ATPase inhibitor
0,171  0,149  Antineoplastic (ovarian cancer)
0,152  0,130  Antiparasitic
0,075  0,054  Antitreponemal
0,150  0,129  Anticonvulsant
0,081  0,061  Antiprotozoal activity enhancer
0,154  0,135  Antiglaucomic
0,160  0,144  Cytostatic
0,067  0,052  SULT2A1 substrate
0,039  0,024  Nicotinic receptor beta4 subunit antagonist
0,163  0,149  Antineoplastic (liver cancer)
0,050  0,037  5 Hydroxytryptamine 4 antagonist
0,125  0,113  Adenylate cyclase stimulant
0,168  0,156  5 Hydroxytryptamine release stimulant
0,037  0,026  5-Alpha-reductase inhibitor
0,071  0,060  SULT1A2 substrate
0,094  0,083  Cystathionine beta-synthase inhibitor
0,098  0,088  DNA polymerase I inhibitor
0,190  0,182  Antihypertensive
0,049  0,041  Protein 50S ribosomal subunit inhibitor
0,135  0,127  Hepatoprotectant
0,103  0,096  Cyclooxygenase 1 inhibitor
0,033  0,027  HMG CoA reductase inhibitor
0,019  0,013  Antibiotic Anthracycline-like
0,094  0,088  SULT1A1 substrate
0,085  0,079  Creatine kinase inhibitor
0,166  0,162  RNA-directed DNA polymerase inhibitor
0,129  0,126  Antiviral (Hepatitis C)
0,032  0,032  Ceramide glucosyltransferase inhibitor

